3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Unknown
1
Terminated
1
Sponsor Class
INDUSTRY
4
OTHER
2
NIH
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Carcinoma, Ovarian Epithelial
2
Pancreatic Neoplasms
1
Interventions
Carboplatin
44
Paclitaxel
41
Cyclophosphamide
21
Topotecan
19
Cisplatin
18
Peripheral Blood Stem Cell Transplantation
15
Filgrastim
15
Docetaxel
15
Gemcitabine
13
Bevacizumab
13
liposomal doxorubicin
11
Hyperthermic Intraperitoneal Chemotherapy
11
sargramostim
9
Therapeutics
8
Immunohistochemistry
8
Psychiatric Rehabilitation
7
Drug Therapy
7
Amifostine
7
pembrolizumab
6
olaparib
6
Taxes
6
Surveys and Questionnaires
6
Melphalan
6
Flow Cytometry
6
Early Intervention, Educational
6
Chemotherapy, Adjuvant
6
niraparib
5
denileukin diftitox
5
Surgical Procedures, Operative
5
Immunoenzyme Techniques
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Ovarian Epithelial
×
oregovomab
×
Clear all
NCT03100006
2022-06-13
ORION-01
National Cancer Centre, Singapore
Phase 1/2
Terminated
13 enrolled
NCT04620954
2021-12-01
ORION-02
National Cancer Centre, Singapore
Phase 1/2
Unknown
31 enrolled